$CRCL-20.11%$NBIS+0.67%called by @SteveUrkelDude$AXTI+6.21%called by @PolarizingLit$SNDK0.00%$ONTO+4.61%$RKLB-2.84%called by @SteveUrkelDude$GEV+3.03%$NKTR-1.86%called by @LTbioinvestor$MP+0.02%$ALAB-1.70%$AAOI+18.94%called by @MarcJacksonLA$AMD+1.33%$INTC+0.11%$CRML-3.27%$AEHR+5.49%called by @RodmanM1$MU-2.18%called by @SteveUrkelDude$OPTX+4.09%$CRCL-20.11%$NBIS+0.67%called by @SteveUrkelDude$AXTI+6.21%called by @PolarizingLit$SNDK0.00%$ONTO+4.61%$RKLB-2.84%called by @SteveUrkelDude$GEV+3.03%$NKTR-1.86%called by @LTbioinvestor$MP+0.02%$ALAB-1.70%$AAOI+18.94%called by @MarcJacksonLA$AMD+1.33%$INTC+0.11%$CRML-3.27%$AEHR+5.49%called by @RodmanM1$MU-2.18%called by @SteveUrkelDude$OPTX+4.09%
Morning BriefingTuesday, Jun 9, 2026
Buy Zone5 picks: ONDS, SMCI, NVTS…
Exit Alerts0 warnings issued
Fear & GreedGREED67
SPY ETF+0.78% (Pre-Market)
Livesync 0s ago
Callers
Cross-validated
Leaderboard #101

@OzmosiHealth

Was 8 days early on $SNSE. Called 2 different winners pre-run.

View @OzmosiHealth on X
Score
0.265
0.5+ = strong
Best lead
8d
on $SNSE
Winners
2
cross-validated
Pre-run tweets
2
substantive only

Calls breakdown

$MANECalled 1 day before runRunning
first mention: Mar 18, 2026
$MANE Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting More Info: pryzm.ozmosi.com/product/331…
$SNSECalled 8 days before runClosed
first mention: Apr 24, 2024
$SNSE Sensei Biotherapeutics will present key clinical data from the SNS-101 Phase I dose escalation study at the 2024 ASCO Annual Meeting. More Info: pryzm.ozmosi.com/product/266… $XBI $IBB $XPH $PPH